Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

SARS-CoV-2 vaccines are effective at limiting disease severity, but effectiveness is lower among patients with cancer or immunosuppression. Effectiveness wanes with time and varies by vaccine type. Moreover, previously prescribed vaccines were based on the ancestral SARS-CoV-2 spike-protein that eme...

Descripción completa

Detalles Bibliográficos
Autores principales: Voutouri, Chrysovalantis, Hardin, C. Corey, Naranbhai, Vivek, Nikmaneshi, Mohammad R., Khandekar, Melin J., Gainor, Justin F., Stylianopoulos, Triantafyllos, Munn, Lance L., Jain, Rakesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2023
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934028/
https://www.ncbi.nlm.nih.gov/pubmed/36623200
http://dx.doi.org/10.1073/pnas.2211132120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934028/
https://www.ncbi.nlm.nih.gov/pubmed/36623200
http://dx.doi.org/10.1073/pnas.2211132120

Ejemplares similares